Background: West Nile virus (WNV) is a single-stranded RNA virus that may trigger neurological illness in each people and horses. As a result of motion of competent vectors and viraemic hosts, WNV has repeatedly emerged globally and extra not too long ago in western Europe. Throughout the UK, WNV is a notifiable illness in horses, and vaccines towards the virus are commercially accessible. Nonetheless, there was no investigation into the seroprevalence of WNV within the UK equine inhabitants to find out the extent of vaccination or to supply proof of latest an infection.
Strategies: Equine serum samples have been obtained from the Animal and Plant Well being Company’s equine testing service between August and November 2019. A complete of 988 serum samples have been chosen for horses resident in South East England. WNV seroprevalence was decided utilizing two enzyme-linked immunosorbent assays (ELISAs) to detect whole flavivirus antibodies and WNV-specific immunoglobulin M (IgM) antibodies. Constructive IgM outcomes have been investigated by contacting the submitting veterinarian to determine the medical historical past or proof of prior vaccination of the horses in query.
Outcomes: Throughout the cohort, 274 samples examined constructive for flavivirus antibodies, of which two subsequently examined constructive for WNV-specific IgM antibodies. The follow-up investigation established that each horses had been vaccinated previous to serum samples being drawn, which resulted in an IgM-positive response. All of the samples that examined constructive by competitors ELISA have been from horses set to be exported to international locations the place WNV is endemic. Consequently, the constructive outcomes have been possible resulting from earlier vaccination. In distinction, 714 samples have been seronegative, indicating that almost all of the UK equine inhabitants could also be vulnerable to WNV an infection.
Conclusions: There was no proof for cryptic WNV an infection in a cohort of horses sampled in England in 2019. All IgM-seropositive circumstances have been resulting from vaccination; this needs to be famous for future epidemiological surveys within the occasion of a illness outbreak, as it isn’t potential to tell apart vaccinated from contaminated horses with out data of their medical histories.
PODO447: a novel antibody to a tumor-restricted epitope on the most cancers antigen podocalyxin
Background: The success of latest focused most cancers therapies has been depending on the identification of tumor-specific antigens. Podocalyxin (Podxl) is upregulated on tumors with excessive metastatic index and its presence is related to poor consequence, thus rising as an essential prognostic and theragnostic marker in a number of human cancers. Furthermore, in human tumor xenograft fashions, Podxl expression promotes tumor development and metastasis. Though a promising goal for immunotherapy, the expression of Podxl on regular vascular endothelia and kidney podocytes might hamper efforts to therapeutically goal this molecule. Since pathways regulating post-translational modifications are ceaselessly perturbed in most cancers cells, we sought to supply novel anti-Podxl antibodies (Abs) that selectively acknowledge tumor-restricted glycoepitopes on the extracellular mucin area of Podxl.
Strategies: Splenic B cells have been remoted from rabbits immunized with a Podxl-expressing human tumor cell line. Abs from these B cells have been screened for potent reactivity to Podxl+ neoplastic cell strains however not Podxl+ major endothelial cells. Transcripts encoding heavy and light-weight chain variable areas from promising B cells have been cloned and expressed as recombinant proteins. Tumor specificity was assessed utilizing major regular tissue and an ovarian most cancers tissue microarray (TMA). Mapping of the tumor-restricted epitope was carried out utilizing enzyme-treated human tumor cell strains and a glycan array.
Outcomes: One mAb (PODO447) confirmed robust reactivity with quite a lot of Podxl+ tumor cell strains however not with regular major human tissue together with Podxl+ kidney podocytes and most vascular endothelia. Screening of an ovarian carcinoma TMA (219 circumstances) revealed PODO447 reactivity with the vast majority of tumors, together with 65% of the high-grade serous histotype. Subsequent biochemical analyses decided that PODO447 reacts with a extremely uncommon terminal N-acetylgalactosamine beta-1 (GalNAcβ1) motif predominantly discovered on the Podxl protein core. Lastly, Ab-drug conjugates confirmed particular efficacy in killing tumor cells in vitro.
Conclusions: We have now generated a novel and exquisitely tumor-restricted mAb, PODO447, that acknowledges a glycoepitope on Podxl expressed at excessive ranges by quite a lot of tumors together with the vast majority of life-threatening high-grade serous ovarian tumors. Thus, tumor-restricted PODO447 displays the suitable specificity for additional improvement as a focused immunotherapy.
Auto-antibodies towards apolipoprotein A-1 block most cancers cells proliferation and induce apoptosis
Auto-antibodies towards apoA-1 (anti-apoA-1 IgGs) have been recognized as essential actors of atherosclerosis improvement by way of pro-inflammatory and pro-atherogenic properties and to additionally induce apoptosis in tumoral neuronal and lymphocyte derived cell strains by way of unknown mechanisms. The aim of this examine was to discover the mobile pathways concerned in tumoral cell survival modulated by anti-apoA-1 antibodies.
We noticed that anti-apoA-1 antibodies induce development arrest (in G2/M section) and cell apoptosis by way of caspase three activation, accompanied by a selective p53 phosphorylation on serine 15. RNA sequencing indicated that anti-apoA-1 IgGs have an effect on the expression of greater than 950 genes belonging to 5 main teams of genes and respectively concerned in i) cell proliferation inhibition, ii) p53 stabilisation and regulation, iii) apoptosis regulation, iv) irritation regulation, and v) oxidative stress.
Anti-SRY Antibody |
A00614-1 |
BosterBio |
100ug/vial |
EUR 352.8 |
anti-SRY (1G4) |
LF-MA30760 |
Abfrontier |
100 ul |
EUR 632.4 |
Description: Mouse Monoclonal to SRY |
anti- SRY antibody |
FNab08244 |
FN Test |
100µg |
EUR 702 |
|
Description: Antibody raised against SRY |
Anti-SRY antibody |
STJ111655 |
St John's Laboratory |
100 µl |
EUR 332.4 |
Description: This intronless gene encodes a transcription factor that is a member of the high mobility group (HMG)-box family of DNA-binding proteins. This protein is the testis-determining factor (TDF), which initiates male sex determination. Mutations in this gene give rise to XY females with gonadal dysgenesis (Swyer syndrome); translocation of part of the Y chromosome containing this gene to the X chromosome causes XX male syndrome. |
Anti-SRY antibody |
STJ95789 |
St John's Laboratory |
200 µl |
EUR 236.4 |
Description: Rabbit polyclonal to SRY. |
Anti-SRY antibody |
STJ96862 |
St John's Laboratory |
200 µl |
EUR 236.4 |
Description: Rabbit polyclonal to SRY. |
Rabbit Polyclonal antibody Anti-CRBN |
Anti-CRBN |
ImmunoStep |
50 µg |
EUR 418.8 |
SRY antibody |
70R-50422 |
Fitzgerald |
100 ul |
EUR 292.8 |
Description: Purified Polyclonal SRY antibody |
SRY antibody |
70R-20531 |
Fitzgerald |
50 ul |
EUR 522 |
Description: Rabbit polyclonal SRY antibody |
SRY antibody |
70R-31829 |
Fitzgerald |
100 ug |
EUR 392.4 |
Description: Rabbit polyclonal SRY antibody |
SRY Antibody |
33859-100ul |
SAB |
100ul |
EUR 302.4 |
SRY Antibody |
33859-50ul |
SAB |
50ul |
EUR 224.4 |
SRY Antibody |
1-CSB-PA050154 |
Cusabio |
|
|
|
Description: A polyclonal antibody against SRY. Recognizes SRY from Human. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/20000 |
SRY Antibody |
CSB-PA985423- |
Cusabio |
|
EUR 402 |
|
Description: A polyclonal antibody against SRY. Recognizes SRY from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000 |
SRY Antibody |
CSB-PA985423-100ul |
Cusabio |
100ul |
EUR 379.2 |
|
Description: A polyclonal antibody against SRY. Recognizes SRY from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000 |
SRY Antibody |
1-CSB-PA022699GA01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against SRY. Recognizes SRY from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC |
Sry Antibody |
1-CSB-PA022699LA01MO |
Cusabio |
|
|
|
Description: A polyclonal antibody against Sry. Recognizes Sry from Mouse. This antibody is Unconjugated. Tested in the following application: ELISA |
SRY Antibody |
1-CSB-PA005928 |
Cusabio |
|
|
|
Description: A polyclonal antibody against SRY. Recognizes SRY from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000 |
Polyclonal Goat anti-GST α-form |
GST-ANTI-1 |
Detroit R&D |
50 uL |
EUR 336 |
Polyclonal Goat anti-GST μ-form |
GST-ANTI-2 |
Detroit R&D |
50 uL |
EUR 336 |
Polyclonal Goat anti-GST p-form |
GST-ANTI-3 |
Detroit R&D |
50 uL |
EUR 336 |
Bovine Sex- determining region Y protein, SRY ELISA KIT |
ELI-29876b |
Lifescience Market |
96 Tests |
EUR 1113.6 |
SRY Polyclonal Antibody |
41868-100ul |
SAB |
100ul |
EUR 302.4 |
SRY Polyclonal Antibody |
41868-50ul |
SAB |
50ul |
EUR 224.4 |
SRY Polyclonal Antibody |
ABP56287-003ml |
Abbkine |
0.03ml |
EUR 189.6 |
|
Description: A polyclonal antibody for detection of SRY from Human. This SRY antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human SRY at AA range: 30-110 |
SRY Polyclonal Antibody |
ABP56287-01ml |
Abbkine |
0.1ml |
EUR 346.8 |
|
Description: A polyclonal antibody for detection of SRY from Human. This SRY antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human SRY at AA range: 30-110 |
SRY Polyclonal Antibody |
ABP56287-02ml |
Abbkine |
0.2ml |
EUR 496.8 |
|
Description: A polyclonal antibody for detection of SRY from Human. This SRY antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human SRY at AA range: 30-110 |
SRY Polyclonal Antibody |
ABP53228-003ml |
Abbkine |
0.03ml |
EUR 189.6 |
|
Description: A polyclonal antibody for detection of SRY from Human. This SRY antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human SRY |
SRY Polyclonal Antibody |
ABP53228-01ml |
Abbkine |
0.1ml |
EUR 346.8 |
|
Description: A polyclonal antibody for detection of SRY from Human. This SRY antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human SRY |
SRY Polyclonal Antibody |
ABP53228-02ml |
Abbkine |
0.2ml |
EUR 496.8 |
|
Description: A polyclonal antibody for detection of SRY from Human. This SRY antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human SRY |
SRY Blocking Peptide |
20-abx063297 |
Abbexa |
|
|
|
SRY Rabbit pAb |
A9323-100ul |
Abclonal |
100 ul |
EUR 369.6 |
SRY Rabbit pAb |
A9323-200ul |
Abclonal |
200 ul |
EUR 550.8 |
SRY Rabbit pAb |
A9323-20ul |
Abclonal |
20 ul |
Ask for price |
SRY Rabbit pAb |
A9323-50ul |
Abclonal |
50 ul |
EUR 267.6 |
Polyclonal SRY Antibody |
APR05561G |
Leading Biology |
0.1ml |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SRY . This antibody is tested and proven to work in the following applications: |
SRY Blocking Peptide |
BF0037-BP |
Affbiotech |
1mg |
EUR 234 |
SRY Blocking Peptide |
DF3242-BP |
Affbiotech |
1mg |
EUR 234 |
SRY Conjugated Antibody |
C33859 |
SAB |
100ul |
EUR 476.4 |
SRY Polyclonal Antibody |
ES4227-100ul |
ELK Biotech |
100ul |
EUR 334.8 |
Description: A Rabbit Polyclonal antibody against SRY from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
SRY Polyclonal Antibody |
ES4227-50ul |
ELK Biotech |
50ul |
EUR 248.4 |
Description: A Rabbit Polyclonal antibody against SRY from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
SRY Polyclonal Antibody |
ES7286-100ul |
ELK Biotech |
100ul |
EUR 334.8 |
Description: A Rabbit Polyclonal antibody against SRY from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
SRY Polyclonal Antibody |
ES7286-50ul |
ELK Biotech |
50ul |
EUR 248.4 |
Description: A Rabbit Polyclonal antibody against SRY from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
Sry Polyclonal Antibody |
A53594-020 |
EpiGentek |
20 ul |
EUR 117.7 |
Sry Polyclonal Antibody |
A53594-050 |
EpiGentek |
50 ul |
EUR 302.5 |
Sry Polyclonal Antibody |
A53594-100 |
EpiGentek |
100 ul |
EUR 423.5 |
Sry Polyclonal Antibody |
A53594 |
EpiGentek |
-
EUR 684.66
-
EUR 117.70
-
EUR 302.50
-
EUR 423.50
|
- 100 µg
- 20 ul
- 50 ul
- 100 ul
|
Polyclonal SRY Antibody (Center) |
APR04854G |
Leading Biology |
0.1ml |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SRY (Center). This antibody is tested and proven to work in the following applications: |
Human SRY shRNA Plasmid |
20-abx954602 |
Abbexa |
|
|
|
Mouse SRY shRNA Plasmid |
20-abx973051 |
Abbexa |
|
|
|
Sry Antibody, HRP conjugated |
1-CSB-PA022699LB01MO |
Cusabio |
|
|
|
Description: A polyclonal antibody against Sry. Recognizes Sry from Mouse. This antibody is HRP conjugated. Tested in the following application: ELISA |
Sry Antibody, FITC conjugated |
1-CSB-PA022699LC01MO |
Cusabio |
|
|
|
Description: A polyclonal antibody against Sry. Recognizes Sry from Mouse. This antibody is FITC conjugated. Tested in the following application: ELISA |
Sry Antibody, Biotin conjugated |
1-CSB-PA022699LD01MO |
Cusabio |
|
|
|
Description: A polyclonal antibody against Sry. Recognizes Sry from Mouse. This antibody is Biotin conjugated. Tested in the following application: ELISA |
SRY Recombinant Protein (Rat) |
RP231140 |
ABM |
100 ug |
Ask for price |
SRY Recombinant Protein (Human) |
RP100173 |
ABM |
100 ug |
Ask for price |
SRY Recombinant Protein (Mouse) |
RP175568 |
ABM |
100 ug |
Ask for price |
Rabbit anti Bovine |
E61I02501 |
EnoGene |
0.1mg |
EUR 411.6 |
SRY-Box 11 (SOX11) Antibody |
20-abx008690 |
Abbexa |
-
EUR 360.00
-
EUR 526.80
-
EUR 226.80
|
|
|
SRY-Box 21 (SOX21) Antibody |
20-abx333756 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
SRY-Box 11 (SOX11) Antibody |
20-abx338917 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
SRY-Box 21 (SOX21) Antibody |
20-abx218722 |
Abbexa |
|
|
|
SRY-Box 11 (SOX11) Antibody |
abx431605-200ul |
Abbexa |
200 ul |
EUR 343.2 |
|
SRY-Box 11 (SOX11) Antibody |
abx431606-200ul |
Abbexa |
200 ul |
EUR 460.8 |
|
SRY-Box 21 (SOX21) Antibody |
abx431698-200ul |
Abbexa |
200 ul |
EUR 343.2 |
|
SRY-Box 11 (SOX11) Antibody |
20-abx214145 |
Abbexa |
|
|
|
SRY-Box 11 (SOX11) Antibody |
20-abx241421 |
Abbexa |
|
|
|
Polyclonal SRY Antibody (N-Term) |
APR04847G |
Leading Biology |
0.1ml |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SRY (N-Term). This antibody is tested and proven to work in the following applications: |
Monoclonal SRY Antibody, Clone: 1G4 |
APR13546G |
Leading Biology |
0.1ml |
EUR 633.6 |
Description: A Monoclonal antibody against Human SRY. The antibodies are raised in Mouse and are from clone 1G4. This antibody is applicable in WB and IHC, FC, E |
Sry ORF Vector (Rat) (pORF) |
ORF077048 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Sry ORF Vector (Mouse) (pORF) |
ORF058524 |
ABM |
1.0 ug DNA |
EUR 607.2 |
SRY ELISA Kit (Dog) (OKEH08706) |
OKEH08706 |
Aviva Systems Biology |
96 Wells |
EUR 1420.8 |
Description: Description of target: ;Species reactivity: Dog;Application: ELISA;Assay info: Assay Methodology: Quantitative Competitive ELISA;Sensitivity: 0.098ng/ml |
SRY ORF Vector (Human) (pORF) |
ORF033392 |
ABM |
1.0 ug DNA |
EUR 486 |
SRY Colorimetric Cell-Based ELISA |
EKC1778 |
BosterBio |
100ul |
EUR 686.4 |
SRY ELISA Kit (Human) (OKCD08916) |
OKCD08916 |
Aviva Systems Biology |
96 Wells |
EUR 1170 |
Description: Description of target: SRY is an intronless gene that encodes for a transcription factor, which is a member of the high mobility group (HMG)-box family of DNA-binding proteins. This protein is the testis-determining factor(TDF), which initiates male sex determination. Mutations in this gene give rise to XY females with gonadal dysgenesis (Swyer syndrome); translocation of part of the Y chromosome containing this gene to the X chromosome causes XX male syndrome.This intronless gene encodes a transcription factor that is a member of the high mobility group (HMG)-box family of DNA-binding proteins. This protein is the testis-determining factor (TDF), which initiates male sex determination. Mutations in this gene give rise to XY females with gonadal dysgenesis (Swyer syndrome); translocation of part of the Y chromosome containing this gene to the X chromosome causes XX male syndrome. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: < 0.055ng/mL |
Sry Polyclonal Antibody, FITC Conjugated |
A53595-050 |
EpiGentek |
50 ul |
EUR 302.5 |
Sry Polyclonal Antibody, FITC Conjugated |
A53595-100 |
EpiGentek |
100 ul |
EUR 423.5 |
Sry Polyclonal Antibody, Biotin Conjugated |
A53596-050 |
EpiGentek |
50 ul |
EUR 302.5 |
Sry Polyclonal Antibody, Biotin Conjugated |
A53596-100 |
EpiGentek |
100 ul |
EUR 423.5 |
Sry Polyclonal Antibody, HRP Conjugated |
A53597-050 |
EpiGentek |
50 ul |
EUR 302.5 |
Sry Polyclonal Antibody, HRP Conjugated |
A53597-100 |
EpiGentek |
100 ul |
EUR 423.5 |
Sry Polyclonal Antibody, FITC Conjugated |
A53595 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Sry Polyclonal Antibody, Biotin Conjugated |
A53596 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Sry Polyclonal Antibody, HRP Conjugated |
A53597 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
SOX9 Antibody / SRY-box 9 |
V8514-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Sox genes comprise a family of genes that are related to the mammalian sex-determining gene SRY. These genes similarly contain sequences that encode for the HMG-box domain, which is responsible for the sequence-specific DNA-binding activity. Sox genes encode putative transcriptional regulators implicated in the decision of cell fates during development and the control of diverse developmental processes. SOX9 plays an important role in the normal skeletal development. It may regulate the expression of other genes involved in chondrogenesis by acting as a transcription factor for these genes. |
SOX9 Antibody / SRY-box 9 |
V8514-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Sox genes comprise a family of genes that are related to the mammalian sex-determining gene SRY. These genes similarly contain sequences that encode for the HMG-box domain, which is responsible for the sequence-specific DNA-binding activity. Sox genes encode putative transcriptional regulators implicated in the decision of cell fates during development and the control of diverse developmental processes. SOX9 plays an important role in the normal skeletal development. It may regulate the expression of other genes involved in chondrogenesis by acting as a transcription factor for these genes. |
SOX9 Antibody / SRY-box 9 |
V8514SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Sox genes comprise a family of genes that are related to the mammalian sex-determining gene SRY. These genes similarly contain sequences that encode for the HMG-box domain, which is responsible for the sequence-specific DNA-binding activity. Sox genes encode putative transcriptional regulators implicated in the decision of cell fates during development and the control of diverse developmental processes. SOX9 plays an important role in the normal skeletal development. It may regulate the expression of other genes involved in chondrogenesis by acting as a transcription factor for these genes. |
Goat anti Bovine IgG |
41C-CB0136 |
Fitzgerald |
5 mg |
EUR 308.4 |
Description: Goat anti Bovine IgG secondary antibody |
Sheep anti Bovine IgG1 |
41R-IS001 |
Fitzgerald |
1 mg |
EUR 289.2 |
Description: Affinity purified Sheep polyclonal Sheep anti Bovine IgG1 antibody |
Rabbit anti Bovine IgA |
41R-RB001 |
Fitzgerald |
1 mg |
EUR 259.2 |
Description: Rabbit anti Bovine IgA secondary antibody |
Sheep anti Bovine IgA |
41R-SB001 |
Fitzgerald |
1 mg |
EUR 259.2 |
Description: Sheep anti Bovine IgA secondary antibody |
Rabbit anti Bovine IgG |
40C-CB0115 |
Fitzgerald |
2 mg |
EUR 337.2 |
Description: Rabbit anti Bovine IgG secondary antibody |
Rabbit anti Bovine IgG |
40C-CB0129 |
Fitzgerald |
5 mg |
EUR 416.4 |
Description: Rabbit anti Bovine IgG secondary antibody |
Sheep anti Bovine IgM |
40C-CB0143 |
Fitzgerald |
1 mg |
EUR 243.6 |
Description: Sheep anti Bovine IgM secondary antibody |
Sheep anti Bovine IgG1 |
20R-IS001 |
Fitzgerald |
1 mg |
EUR 289.2 |
Description: Sheep anti Bovine IgG1 antibody |
Anti-Bovine Plasma Proteins |
BPP04 |
Cygnus Technologies |
1 ml |
EUR 400.8 |
|
Description: Anti-Bovine Plasma Proteins by Cygnus Technologies is available in Europe via Gentaur. |
Anti-Bovine Plasma Proteins |
BPP04-AF |
Cygnus Technologies |
1 mg |
EUR 2295.6 |
|
Description: Anti-Bovine Plasma Proteins by Cygnus Technologies is available in Europe via Gentaur. |
Anti-Bovine Plasma Proteins |
BPP04-PA |
Cygnus Technologies |
1 ml |
EUR 585.6 |
|
Description: Anti-Bovine Plasma Proteins by Cygnus Technologies is available in Europe via Gentaur. |
Anti-Bovine Plasma Proteins |
BPP04AF-HRP |
Cygnus Technologies |
100 ul |
EUR 1186.8 |
|
Description: Anti-Bovine Plasma Proteins by Cygnus Technologies is available in Europe via Gentaur. |
Anti-Bovine IgG:HRP Conjugate |
F071 |
Cygnus Technologies |
12 ml |
EUR 632.4 |
|
Description: Anti-Bovine IgG:HRP Conjugate by Cygnus Technologies is available in Europe via Gentaur. |
Anti-Bovine Transferrin:HRP Conjugate |
F123 |
Cygnus Technologies |
12 ml |
EUR 585.6 |
|
Description: Anti-Bovine Transferrin:HRP Conjugate by Cygnus Technologies is available in Europe via Gentaur. |
Anti-bovine IgG antibody |
STJ15100020 |
St John's Laboratory |
250 µg |
EUR 348 |
Description: This monoclonal antibody (mAb) enables sensitive and specific detection of bovine IgG in immunoassays such as ELISA and ELISpot. |
Anti-bovine IgG antibody |
STJ15100021 |
St John's Laboratory |
250 µg |
EUR 391.2 |
Description: This monoclonal antibody enables sensitive and specific detection of human IgG in immunoassays such as ELISA and ELISpot. |
Anti-bovine IgG antibody |
STJ15100022 |
St John's Laboratory |
1 ml |
EUR 420 |
Description: This HRP-conjugated monoclonal antibody enables sensitive and specific detection of bovine IgG in ELISA. |
Sex Determining Region Y (SRY) Antibody |
20-abx115499 |
Abbexa |
|
|
|
Sex Determining Region Y (SRY) Antibody |
20-abx128106 |
Abbexa |
-
EUR 510.00
-
EUR 159.60
-
EUR 1446.00
-
EUR 693.60
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
In conclusion, anti-apoA-1 antibodies appear to have a task in blocking tumoral cell proliferation and survival, by activating a serious tumor suppressor protein and by modulating the inflammatory and oxidative stress response. Additional investigations are wanted to discover a potential anti-cancer therapeutic method of those antibodies in very particular and circumscribed situations.